NEW DELHI: The Supreme Court ruled in favor of the popular painkiller Saridon, exempting its formulation from the list of prohibited fixed-dose combinations (FDC), Reuters said.
In early September of last year, Piramal received an order of suspension of the Supreme Court on the ban, which allowed him to continue the manufacture, distribution and sale of the brand Saridon painkiller.
Nandini Piramal, CEO of Piramal Enterprises Limited said they were confident the law would prevail in their favor.
“Saridon is an inherited brand that customers trust in the last 50 years in India. This exemption from the forbidden list of FDC validates our intention to serve our clients with the highest levels of integrity. We continue to expand our portfolio of health care products with the goal of being among the top three OTC (over-the-counter) products companies in India by the year 2020, “he said in a statement from the stock exchange.
Saridon is among the most widely distributed analgesic tablets in India with a solid distribution network in 9 lakh stores in India. According to a survey conducted by AC Neilson, in India, 31 tablets of Saridon are sold every second.